Maghawry Hegazy

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Clostridium Difficile

Methicillin Resistant Staphylococcus Aureus

Structure Activity Relationship

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Mohamed Hagras, Abdelrahman A Abuelkhir, Nader S Abutaleb, Ahmed M Helal, Iten M Fawzy, Maghawry Hegazy, Mohamed N Seleem, Abdelrahman S Mayhoub
Novel phenylthiazoles with a tert -butyl moiety: promising antimicrobial activity against multidrug-resistant pathogens with enhanced ADME properties. RSC advances 14 (2) (2024)
Mohamed Hagras, Abdelrahman A Abuelkhir, Nader S Abutaleb, Ahmed M Helal, Iten M Fawzy, Maghawry Hegazy, Mohamed N Seleem, Abdelrahman S Mayhoub
Novel phenylthiazoles with a tert -butyl moiety: promising antimicrobial activity against multidrug-resistant pathogens with enhanced ADME properties. RSC advances 14 (2) (2024)
Omnia R Elbatrawy, Mohamed Hagras, Moshira A El Deeb, Fatimah Agili, Maghawry Hegazy, Ahmed A El-Husseiny, Mahmoud Mohamed Mokhtar, Samy Y Elkhawaga, Ibrahim H Eissa, Samar A El-Kalyoubi
Discovery of New Uracil and Thiouracil Derivatives as Potential HDAC Inhibitors. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)